Niket Patel

Director, Drug Product Technical Operations at Mineralys Therapeutics

Niket Patel has extensive work experience in the pharmaceutical industry. Niket is currently serving as the Director of Drug Product Technical Operations at Mineralys Therapeutics, Inc. since June 2023. Previously, from March 2021 to June 2023, they worked as a Senior Manager of Drug Development at Albireo Pharma, Inc. Before that, they held various roles at Quotient Sciences from November 2017 to March 2021, including Senior Group Leader, Group Leader, and Research Scientist. Prior to that, they worked as a Senior Formulation Scientist at Charles River Laboratories from June 2016 to November 2017, and as a Formulation Scientist at QS Pharma from July 2014 to June 2016. Niket also gained valuable experience as a Product Development Scientist at Ohm Laboratories, Inc. from June 2013 to June 2014. Furthermore, they pursued their doctoral studies and served as a Teaching Fellow at St. Johns' University from September 2009 to December 2013. In addition, they obtained their Master's degree in Industrial Pharmacy from St. Johns' University from January 2007 to December 2008. Their professional career started as an Intern at Wockhardt LTD. from June 2006 to September 2006, where they gained experience in tablet and liquid oral dosage form manufacturing and quality control tests following GMP regulations.

Niket Patel's education history is as follows:

From 2015 to 2017, Niket Patel attended Goldey-Beacom College and obtained a Master of Business Administration (MBA) degree with a field of study in Health/Health Care Administration/Management.

Between 2009 and 2013, Niket Patel pursued a Doctor of Philosophy (Ph.D.) degree in Industrial Pharmacy from St. John's University.

In 2007 and 2008, Niket Patel attended St. John's University again to earn a Master of Science (MS) degree in Industrial Pharmacy.

From 2002 to 2006, Niket Patel completed a Bachelor of Pharmacy (B.Pharm.) degree at L.M. College of Pharmacy.

Niket Patel also possesses a certification as a 2013 Level II CFA Candidate from the CFA Institute, but the exact month and year of obtaining the certification are not provided.

Links


Timeline

  • Director, Drug Product Technical Operations

    June, 2023 - present